University of California San Francisco
Give to UCSF
Women who receive a breast cancer diagnosis while they are still young enough to bear children can take time to freeze their eggs and embryos without fear of delaying their cancer treatment.
UCSF Benioff Children’s Hospitals will pioneer stem cell transplants for a uniquely challenging patient population: second-trimester fetuses stricken with a potentially fatal disease.
Clinical trials that test changes in the design or use of high-risk medical devices are often poorly designed, and can rely on inadequate or potentially biased data.
In a new collaboration, ShangPharma Innovation, Inc. is providing funding and other support to scientists at UC San Francisco to accelerate the development of promising life science inventions.
Google search volume across the United States could help fill in the gaps on cancer incidence and mortality data, according to a new study by scientists at UCSF and the University of Pennsylvania.
Crowdsourcing for health and medical research leads to certain groups being either over- or underrepresented by age, race/ethnicity, education and physical activity, according to a UCSF-led study.
Organoids serve as dioramas of disease, allowing UCSF scientists to understand how and why problems occur during tissue development. It's also a small step toward the creation of full-sized organs we could use for transplant.
By piercing liver cells with rapid pulses of electricity, scientists at UC San Francisco have demonstrated an entirely new way to transplant cells into organs to treat disease.
A video game under development as a medical device boosts attention in some children with sensory processing dysfunction.
A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis is holding new hope for the hundreds of thousands Americans living with the disease. It also highlights the importance of clinician scientists like UCSF’s Stephen Hauser who are working to transform research into cures for patients.
An innovative virtual glucose management service for hospitalized patients with diabetes is highly effective at maintaining appropriate glucose levels.
Location-tracking apps on smartphones could be used to help track and manage care for thousands of patients who suffer from chronic diseases, and possibly provide feedback to them on lifestyle changes.
UCSF is the lead institution on a California-based, six-university consortium that was awarded $12 million by the NIDCR to develop strategies for treating craniofacial and dental defects.
In an unprecedented leap from lab to patients, a potential treatment for childhood epilepsy identified in experiments with zebrafish.
